These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 18471546)
41. [Non-invasive and early diagnosis of liver cirrhosis]. Pilette C; Croquet V; Vuillemin E; Oberti F; Calès P Gastroenterol Clin Biol; 1999 May; 23(5):557-65. PubMed ID: 10429863 [No Abstract] [Full Text] [Related]
42. Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virus. Tural C; Tor J; Sanvisens A; Pérez-Alvarez N; Martínez E; Ojanguren I; García-Samaniego J; Rockstroh J; Barluenga E; Muga R; Planas R; Sirera G; Rey-Joly C; Clotet B Clin Gastroenterol Hepatol; 2009 Mar; 7(3):339-45. PubMed ID: 19171202 [TBL] [Abstract][Full Text] [Related]
43. Non-invasive model predicting clinically-significant portal hypertension in patients with advanced fibrosis. Park SH; Park TE; Kim YM; Kim SJ; Baik GH; Kim JB; Kim DJ J Gastroenterol Hepatol; 2009 Jul; 24(7):1289-93. PubMed ID: 19682196 [TBL] [Abstract][Full Text] [Related]
44. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Naveau S; Gaudé G; Asnacios A; Agostini H; Abella A; Barri-Ova N; Dauvois B; Prévot S; Ngo Y; Munteanu M; Balian A; Njiké-Nakseu M; Perlemuter G; Poynard T Hepatology; 2009 Jan; 49(1):97-105. PubMed ID: 19053048 [TBL] [Abstract][Full Text] [Related]
45. Optimized stepwise combination algorithms of non-invasive liver fibrosis scores including Hepascore in hepatitis C virus patients. Bourliere M; Penaranda G; Ouzan D; Renou C; Botta-Fridlund D; Tran A; Rosenthal E; Wartelle-Bladou C; Delasalle P; Oules V; Portal I; Castellani P; Lecomte L; Rosenthal-Allieri MA; Halfon P Aliment Pharmacol Ther; 2008 Aug; 28(4):458-67. PubMed ID: 18498446 [TBL] [Abstract][Full Text] [Related]
47. Are non-invasive tests accurate enough to predict hepatic fibrosis in non-alcoholic fatty liver disease (NAFLD)? Chavez-Tapia NC; Tiribelli C Gut; 2008 Oct; 57(10):1351-3. PubMed ID: 18791116 [No Abstract] [Full Text] [Related]
48. Genesis of hepatic fibrosis and its biochemical markers. Das SK; Vasudevan DM Scand J Clin Lab Invest; 2008; 68(4):260-9. PubMed ID: 18609066 [TBL] [Abstract][Full Text] [Related]
49. The quest for liver fibrosis biomarkers: promises from the enhanced liver fibrosis panel and beyond. Yilmaz Y; Ulukaya E; Dolar E Hepatology; 2009 Mar; 49(3):1056-7. PubMed ID: 19133647 [No Abstract] [Full Text] [Related]
50. [Value of transient elastography in noninvasive assessment in children's hepatic fibrosis]. Breton E; Bridoux-Henno L; Guyader D; Daniélou H; Jouan H; Beuchée A; Nousbaum JB; Dabadie A Arch Pediatr; 2009 Jul; 16(7):1005-10. PubMed ID: 19446446 [TBL] [Abstract][Full Text] [Related]
51. The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis B. Mallet V; Dhalluin-Venier V; Roussin C; Bourliere M; Pettinelli ME; Giry C; Vallet-Pichard A; Fontaine H; Pol S Aliment Pharmacol Ther; 2009 Feb; 29(4):409-15. PubMed ID: 19035983 [TBL] [Abstract][Full Text] [Related]
53. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy. Lindsay K; Fraser AD; Layton A; Goodfield M; Gruss H; Gough A Rheumatology (Oxford); 2009 May; 48(5):569-72. PubMed ID: 19273538 [TBL] [Abstract][Full Text] [Related]
54. [Methods of early diagnostics of hepatic fibrosis and cirrhosis]. Pavlov ChS; Kogan EA; Shul'pekova IuO; Zolotarevskiĭ VB; Ivashkin VT Klin Med (Mosk); 2006; 84(4):53-5. PubMed ID: 16755858 [TBL] [Abstract][Full Text] [Related]
55. Syndecan 1 (CD138) serum levels: a novel biomarker in predicting liver fibrosis stage in patients with hepatitis C. Zvibel I; Halfon P; Fishman S; Penaranda G; Leshno M; Or AB; Halpern Z; Oren R Liver Int; 2009 Feb; 29(2):208-12. PubMed ID: 18694404 [TBL] [Abstract][Full Text] [Related]
56. [Approaches of preoperative assessment of liver function in cirrhotic patient: current status and future prospects]. Mao YL; Zhang T Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):849-52. PubMed ID: 17260481 [TBL] [Abstract][Full Text] [Related]
57. Diagnosis of liver fibrosis: present and future. Patel K; Bedossa P; Castera L Semin Liver Dis; 2015 May; 35(2):166-83. PubMed ID: 25974902 [TBL] [Abstract][Full Text] [Related]
58. Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis. Alric L; Kamar N; Bonnet D; Danjoux M; Abravanel F; Lauwers-Cances V; Rostaing L Transpl Int; 2009 May; 22(5):568-73. PubMed ID: 19196449 [TBL] [Abstract][Full Text] [Related]
59. Noninvasive monitoring of hepatitis C fibrosis progression. Kotlyar DS; Blonski W; Rustgi VK Clin Liver Dis; 2008 Aug; 12(3):557-71, viii. PubMed ID: 18625428 [TBL] [Abstract][Full Text] [Related]